换一批
换一批Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.
作者：
Kamal N,Bharucha [1]
;
Hermine I,Brunner [2]
;
Inmaculada,Calvo Penadés [1]
;
Irina,Nikishina [2]
;
Nadina,Rubio-Pérez [1]
;
Sheila,Oliveira [2]
;
Katarzyna,Kobusinska [1]
;
Heinrike,Schmeling [2]
;
Flavio,Sztajnbok [1]
;
Frank,Weller-Heinemann [2]
;
Elena,Zholobova [1]
;
Francesco,Zulian [2]
;
Roger,Allen [1]
;
Jeffrey,Chaitow [2]
;
James,Frane [1]
;
Chris,Wells [2]
;
Nicolino,Ruperto [1]
;
Fabrizio,De Benedetti [2]
;
Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group [1]
作者单位：
From Genentech, San Francisco; Consultant, Santa Monica, California, USA; Division of Rheumatology, Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center (CCHMC), Pediatric Rheumatology Collaborative Study Group (PRCSG) Coordinating Center, Cincinnati, Ohio, USA; Paediatric Rheumatology Department, Hospital Universitario La Fe, Valencia, Spain; Pediatric Department, V.A. Nasonova Research Institute of Rheumatology; Department of Pediatric Rheumatology, Hospital of Childhood Diseases, JCA-UNIT, Sechenov Moscow Medical Academy, Moscow, Russia; Department of Pediatrics, Hospital Universitario Dr. J.E. González, Universidad Autónoma de Nuevo, Monterrey, Mexico; Universidade Federal do Rio de Janeiro, Instituto de Puericultura e Pediatria Martagao Gesteira (IPPMG); Hospital Universitario Pedro Ernesto, Nucleo de Estudos da Saúde do Adolescente, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; Wojewodzki Szpital Dzieciecy, Oddzial Pediatrii, Hematologii Onkologii i Reumatologii, Bydgoszcz, Poland; Department of Pediatrics, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada; Klinikum Bremen-Mitte, Professor Hess-Kinderklinik, Pädiatrische Intensivmedizin, Bremen, Germany; Rheumatology Unit, Department of Woman and Child Health, University of Padua, Padua; Istituto Giannina Gaslini, Pediatria II, Rheumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Centre, Genoa; Institute for Research and Health Care (IRCCS) Ospedale Pediatrico Bambino Gesù, Rome, Italy; Royal Children's Hospital, Pediatric Rheumatology, Melbourne, Victoria; Department of Rheumatology, Sydney Children's Hospital Network, Randwick and Westmead, Sydney, Australia; Roche Products Ltd., Welwyn Garden City, UK.
[1]
K.N. Bharucha, PhD, MD, Genentech; H.I. Brunner, MD, MSc, Division of Rheumatology, Department of Pediatrics, University of Cincinnati, CCHMC, PRCSG Coordinating Center; I. Calvo Penadés, MD, PhD, Paediatric Rheumatology Department, Hospital Universitario La Fe; I. Nikishina, MD, PhD, Pediatric Department, V.A. Nasonova Research Institute of Rheumatology; N. Rubio-Pérez, MD, Department of Pediatrics, Hospital Universitario Dr. J.E. González, Universidad Autónoma de Nuevo; S. Oliveira, MD, Universidade Federal do Rio de Janeiro, IPPMG; K. Kobusinska, MD, Wojewodzki Szpital Dzieciecy, Oddzial Pediatrii, Hematologii Onkologii i Reumatologii; H. Schmeling, MD, Department of Pediatrics, Alberta Children's Hospital and University of Calgary; F. Sztajnbok, MD, Hospital Universitario Pedro Ernesto, Nucleo de Estudos da Saúde do Adolescente, Universidade do Estado do Rio de Janeiro; F. Weller-Heinemann, MD, Klinikum Bremen-Mitte, Professor Hess-Kinderklinik, Pädiatrische Intensivmedizin; E. Zholobova, MD, Department of Pediatric Rheumatology, Hospital of Childhood Diseases, JCA-UNIT, Sechenov Moscow Medical Academy; F. Zulian, MD, Rheumatology Unit, Department of Woman and Child Health, University of Padua; R. Allen, MD, Royal Children's Hospital, Pediatric Rheumatology; J. Chaitow, MD, Department of Rheumatology, Sydney Children's Hospital Network; J. Frane, PhD, Consultant; C. Wells, Roche Products Ltd.; N. Ruperto, MD, MPH, Istituto Giannina Gaslini, Pediatria II, Rheumatologia, PRINTO Coordinating Centre; F. De Benedetti, MD, PhD, IRCCS Ospedale Pediatrico Bambino Gesù.
[2]
From Genentech, San Francisco; Consultant, Santa Monica, California, USA; Division of Rheumatology, Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center (CCHMC), Pediatric Rheumatology Collaborative Study Group (PRCSG) Coordinating Center, Cincinnati, Ohio, USA; Paediatric Rheumatology Department, Hospital Universitario La Fe, Valencia, Spain; Pediatric Department, V.A. Nasonova Research Institute of Rheumatology; Department of Pediatric Rheumatology, Hospital of Childhood Diseases, JCA-UNIT, Sechenov Moscow Medical Academy, Moscow, Russia; Department of Pediatrics, Hospital Universitario Dr. J.E. González, Universidad Autónoma de Nuevo, Monterrey, Mexico; Universidade Federal do Rio de Janeiro, Instituto de Puericultura e Pediatria Martagao Gesteira (IPPMG); Hospital Universitario Pedro Ernesto, Nucleo de Estudos da Saúde do Adolescente, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; Wojewodzki Szpital Dzieciecy, Oddzial Pediatrii, Hematologii Onkologii i Reumatologii, Bydgoszcz, Poland; Department of Pediatrics, Alberta Children's Hospital and University of Calgary, Calgary, Alberta, Canada; Klinikum Bremen-Mitte, Professor Hess-Kinderklinik, Pädiatrische Intensivmedizin, Bremen, Germany; Rheumatology Unit, Department of Woman and Child Health, University of Padua, Padua; Istituto Giannina Gaslini, Pediatria II, Rheumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Centre, Genoa; Institute for Research and Health Care (IRCCS) Ospedale Pediatrico Bambino Gesù, Rome, Italy; Royal Children's Hospital, Pediatric Rheumatology, Melbourne, Victoria; Department of Rheumatology, Sydney Children's Hospital Network, Randwick and Westmead, Sydney, Australia; Roche Products Ltd., Welwyn Garden City, UK. fabrizio.debenedetti@opbg.net.
[3]
K.N. Bharucha, PhD, MD, Genentech; H.I. Brunner, MD, MSc, Division of Rheumatology, Department of Pediatrics, University of Cincinnati, CCHMC, PRCSG Coordinating Center; I. Calvo Penadés, MD, PhD, Paediatric Rheumatology Department, Hospital Universitario La Fe; I. Nikishina, MD, PhD, Pediatric Department, V.A. Nasonova Research Institute of Rheumatology; N. Rubio-Pérez, MD, Department of Pediatrics, Hospital Universitario Dr. J.E. González, Universidad Autónoma de Nuevo; S. Oliveira, MD, Universidade Federal do Rio de Janeiro, IPPMG; K. Kobusinska, MD, Wojewodzki Szpital Dzieciecy, Oddzial Pediatrii, Hematologii Onkologii i Reumatologii; H. Schmeling, MD, Department of Pediatrics, Alberta Children's Hospital and University of Calgary; F. Sztajnbok, MD, Hospital Universitario Pedro Ernesto, Nucleo de Estudos da Saúde do Adolescente, Universidade do Estado do Rio de Janeiro; F. Weller-Heinemann, MD, Klinikum Bremen-Mitte, Professor Hess-Kinderklinik, Pädiatrische Intensivmedizin; E. Zholobova, MD, Department of Pediatric Rheumatology, Hospital of Childhood Diseases, JCA-UNIT, Sechenov Moscow Medical Academy; F. Zulian, MD, Rheumatology Unit, Department of Woman and Child Health, University of Padua; R. Allen, MD, Royal Children's Hospital, Pediatric Rheumatology; J. Chaitow, MD, Department of Rheumatology, Sydney Children's Hospital Network; J. Frane, PhD, Consultant; C. Wells, Roche Products Ltd.; N. Ruperto, MD, MPH, Istituto Giannina Gaslini, Pediatria II, Rheumatologia, PRINTO Coordinating Centre; F. De Benedetti, MD, PhD, IRCCS Ospedale Pediatrico Bambino Gesù. fabrizio.debenedetti@opbg.net.
[4]
主题词
青少年(Adolescent);抗风湿药(Antirheumatic Agents);身高(Body Height);儿童(Child);儿童发育(Child Development);儿童, 学龄前(Child, Preschool);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);男(雄)性(Male);治疗结果(Treatment Outcome)
DOI
10.3899/jrheum.170326
PMID
29961686
发布时间
2019-11-11
- 浏览12
The Journal of rheumatology
The Journal of rheumatology
1173-1179页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
